Lutris Pharma
Israel
Establecida en 2015
1-10 empleados
Metallurgy, Chemicals, Rubber & Plastics · Tel Aviv-Yafo
Sector / Industria
Metallurgy, Chemicals, Rubber & Plastics
Descripción de la empresa
Lutris Pharma is developing the topical B-Raf inhibitor LUT014, a proprietary small molecule allowing administration of epidermal growth factor receptor (EGFR) inhibitors to patients without the interruptions caused by typical cutaneous side effects. ...
Productos y servicios
Metallurgy, Chemicals, Rubber & Plastics
PharmaceuticalsHS 30
Material promocional
Para visualizar este contenido
Iniciar sesión